Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × durvalumab × Genitourinary × Clear all

NCT06503614 2026-02-17

ENHANCE

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT03528694 2025-11-25

POTOMAC

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT03317158 2025-01-30

ADAPT-BLADDER

Phase 1/2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04106115 2024-12-04

DURANCE

Phase 1/2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms